ENTA   $12.61  2.69% Market Closed After Close 12.63 0.16%

Enanta Pharmaceuticals Inc
Total Cash 230.08M
totalCashPerShare 10.859
EBITDA -120.34M
Total Debt 226.17M
quickRatio 4.649
currentRatio 4.922
Total Revenue 71.96M
debtToEquity 151.881
Revenue/Share 3.407
ROA -0.1718
ROE -0.59643
grossProfits
freeCashflow -63.27M
operatingCashflow -89.97M
earningsGrowth
revenueGrowth -0.049
grossMargins 1.0
ebitdaMargins -1.67233
operatingMargins -1.34578
profitMargins -1.6026801
enterpriseValue 243.36M
forwardPE -2.4211617
floatShares 15.44M
sharesOutstanding 21.19M
sharesShort 2.99M
sharesShortPriorMonth 2.91M
dateShortInterest
sharesPercentSharesOut 0.14%
heldPercentInsiders 0.06%
heldPercentInstitutions 1.05%
Short Ratio help_outline 17.23%
shortPercentOfFloat 0.15%
impliedSharesOutstanding
bookValue 7.03
Price To Book help_outline 1.66
earningsQuarterlyGrowth
netIncomeToCommon -115.33M
trailingEps -5.45%
forwardEps -4.82%
enterpriseToEbitda -2.02
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.16 3Q 2024
institutionsCount 141
lastUpdated Oct. 16, 2024, 12:25 p.m.